Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
3.100
+0.140 (4.73%)
Aug 13, 2025, 4:00 PM - Market closed

Company Description

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men’s health and oncology in the United States, European Union, and Non-European Union.

The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products.

The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023.

Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

Onconetix, Inc.
Onconetix logo
CountryUnited States
Founded2018
IPO DateFeb 18, 2022
IndustryBiotechnology
SectorHealthcare
Employees5
CEOKarina Fedasz

Contact Details

Address:
201 East Fifth Street, Suite 1900
Cincinnati, Ohio 45202
United States
Phone513 620 4101
Websiteonconetix.com

Stock Details

Ticker SymbolONCO
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$9.00
CIK Code0001782107
CUSIP Number68237Q203
ISIN NumberUS68237Q2030
SIC Code2834

Key Executives

NamePosition
Karina M. FedaszInterim Chief Executive Officer and Interim Chief Financial Officer
Andrew D. Skibo Ph.D.Global Head of Biologics Operations
Dr. Brian Price Ph.D.Head of Technology Strategy
Theodore Scott YohoHead of Business Development
Dr. Ali I. Fattom Ph.D.Head of Science and Discovery
Dr. Jay Newmark M.B.A., M.D.Chief Medical Officer

Latest SEC Filings

DateTypeTitle
Aug 12, 20258-KCurrent Report
Jul 16, 2025SCHEDULE 13D/AFiling
Jul 16, 20258-KCurrent Report
Jun 16, 20258-KCurrent Report
Jun 12, 202510-QQuarterly Report
Jun 11, 20258-KCurrent Report
Jun 5, 20258-KCurrent Report
Jun 2, 202510-KAnnual Report
May 22, 20258-KCurrent Report
May 2, 2025UPLOADFiling